Life Sciences

Ophthalmic Startup Gets $5 Million Investment To Complete Phase 2 Clinical Trials

FARMINGTON HILLS—Ocuphire Pharma Inc., a clinical-stage pharmaceutical company developing therapies to treat patients with a variety of ophthalmic disorders, announced that it has closed on over $5 million of financing. Investors include Jackson-based RBI Opportunities Fund, Douglas, Mich.-based Belle Capital Fund, Grand Rapids-based Grand Angels Fund, Farmington Hills-based First Capital Fund, Ann Arbor-based Michigan Angel

By |2019-07-23T15:35:57-04:00July 23rd, 2019|Life Sciences|

Biotech firm names chief medical officer

ROYAL OAK — OncoCell MDx has hired Kirk Wojno, M.D., as its chief medical officer. OncoCell MDx is developing new, noninvasive molecular diagnostic assays. Wojno, a renowned urologic pathologist and expert in prostate biopsy interpretation, joins an expanding, experienced executive team. OncoCell MDx also recently announced the appointments of Mark McDonough as president and CEO

By |2019-07-20T14:47:15-04:00July 20th, 2019|Life Sciences|

IDTechEx Research Finds 3D Bioprinted Organ Models Key To $1.9 Billion Market

BOSTON  - There is no doubt that 3D bioprinting is a technology of the future. Imagine being able to print a kidney or liver on demand. This is a stark contrast to the long wait for a donor organ today. Currently, the average wait time for a liver is 4 to 5 months and 2.5

By |2019-07-14T18:19:26-04:00July 14th, 2019|Life Sciences, Life Sciences/Biotech|

OptimizeRx Raises $20 Million In Stock Offering

ROCHESTER—OptimizeRx Corp. (Nasdaq: OPRX), the Rochester-based provider of digital communication services for pharmaceutical companies to patients and healthcare providers, has announced a proposed underwritten public offering of shares of its common stock. The company sold 1,538,500 shares of its common stock at a price of $13 per share. The proceeds of the offering, before deducting

By |2019-06-07T18:51:40-04:00June 7th, 2019|ESD, Life Sciences|

Invest Detroit Ventures Portfolio Client Update: Genomenon

ROYAL OAK - Tember Shea, Portfolio Manager for Invest Detroit Ventures, interviews Mike Klein, CEO of Genomenon, to discuss the latest news coming out of the Ann Arbor-based gene therapy company. Mike Klein  To listen, click on https://soundcloud.com/mike-brennan-841872555/e170-genomenon

By |2019-05-17T11:32:15-04:00May 17th, 2019|Life Sciences, M2 TechCast, Podcasts|

Doctors To Host Forum June 8 In Troy To Provide Evidence Supporting Cannabis’ Medical Efficacy

TROY – A group of Michigan doctors is hosting an all-day forum June 8 in an effort to bridge the conversational gap between healthcare providers, patients and the cannabis industry to provide evidence supporting cannabis’ medical efficacy. “For those interested in gaining knowledge and resources regarding the medical benefits of cannabis, it will be extremely

By |2019-05-08T19:45:52-04:00May 8th, 2019|Life Sciences, News|

Genomenon To Make Genomic Data Available On Google Cloud Platform

ANN ARBOR—Genomenon Inc., the Ann Arbor-based genomics research information provider, has announced a partnership with Google to make the company’s genomic mutation data available on Google Cloud platform. Genomenon’s Cited Variants Reference (CVR) data will be a public dataset available in BigQuery, Google Cloud’s big data and machine learning data warehouse, for use in genomic applications. The

By |2019-04-18T16:54:43-04:00April 18th, 2019|Life Sciences, Life Sciences/Biotech|

OptimizeRx Integrates With EHR Systems

ROCHESTER—OptimizeRx Corp., the digital health messaging provider for the pharmaceutical industry, announced its latest platform integration with the health care industry’s leading acute electronic health record (EHR) systems, including Epic and Cerner. This latest announcement is a reflection of the company’s continued investment in hospitals and health systems, also emphasized in the latest company hiring

By |2019-04-10T16:51:54-04:00April 10th, 2019|Life Sciences, Life Sciences/Biotech|

MDEQ To Sample Wells Near Grand Rapids Airport For PFAS

GRAND RAPIDS — The Michigan Department of Environmental Quality announced that it will sample 49 residential drinking water wells along Trout Creek in the neighborhood east of the 36th Street exits off I-96 and west of Tricklewood Drive for per- and polyfluoroalkyl substances (PFAS) as part of its ongoing investigation of potential PFAS contamination sources

By |2019-03-13T12:54:44-04:00March 13th, 2019|ESD, Life Sciences|

Impact Of Urbanization On Wild Bees Underestimated: UM study

ANN ARBOR – Wild bees are indispensable pollinators, supporting both agricultural productivity and the diversity of flowering plants worldwide. But wild bees are experiencing widespread declines resulting from multiple interacting factors. A new University of Michigan-led study suggests that the effects of one of those factors—urbanization—may have been underestimated. The team found that the sex

By |2019-03-10T15:58:21-04:00March 10th, 2019|Life Sciences, Life Sciences/Biotech|